| Bioactivity | Anticancer agent 265 (compound 1) is an anticancer compound. Anticancer agent 265 exhibits in vitro anticancer activity against three human bone cancer lines, U2OS, Saos-2, and GC9811, with IC50 values of 13.1, 11.7, and 14.6 μM, respectively[1]. | ||||||||||||
| CAS | 184177-83-1 | ||||||||||||
| Formula | C30H35N5O3 | ||||||||||||
| Molar Mass | 513.63 | ||||||||||||
| Appearance | 固体 | ||||||||||||
| Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
| Storage |
|
||||||||||||
| Reference | [1]. G Lv, et al. Synthesis, crystal structure, anti-bone cancer activity and molecular docking investigations of the heterocyclic compound 1-((2S, 3S)-2-(benzyloxy) pentan-3-yl)-4-(4-(4-(4-hydroxyphenyl) piperazin-1-yl) phenyl)-1H-1, 2, 4-triazol-5 (4H)-one. Journal of Structural Chemistry 60.7 (2019): 1173-1179. |
Anticancer agent 265
CAS: 184177-83-1 F: C30H35N5O3 W: 513.63
Anticancer agent 265 (compound 1) is an anticancer compound. Anticancer agent 265 exhibits in vitro anticancer activity
Sales Email：peptidedb@qq.com
This product is for research use only, not for human use. We do not sell to patients.